BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,005,000 | -22.4% | 75,947 | -9.8% | 1.01% | -39.7% |
| Q4 2021 | $11,599,000 | -2.1% | 84,170 | -1.3% | 1.68% | -3.9% |
| Q3 2021 | $11,846,000 | +94.9% | 85,280 | -8.8% | 1.75% | +55.2% |
| Q3 2020 | $6,078,000 | +51.0% | 93,498 | +69.8% | 1.12% | +37.2% |
| Q2 2020 | $4,025,000 | +393.3% | 55,055 | +267.3% | 0.82% | +279.6% |
| Q4 2019 | $816,000 | – | 14,990 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |